Penny Powell
Partner
LondonBiography
As partner at Hogan Lovells, Penny has extensive
experience in the life sciences, automotive andtechnology sectors. Understanding her clients’ business
requirements is her key to advising clients on theirmost important commercial transactions, while
maintaining a focus on her specialist industry sectors.
Penny advises on a variety of arrangements that go to
the core of clients' on-going business and has
particular experience of advising on M&A as well as
helping companies structure and negotiate their mostcomplex commercial transactions, including complex
joint venture and collaboration arrangements, licenseand collaboration deals and sourcing/service
arrangements.
Clients turn to Penny for her combined strengths as an
M&A and a commercial transactions lawyer as sheunderstands not just the anatomy of getting a deal tocompletion, but also how a relationship will work out
once the ink has dried on the contracts.
Clients also work with Penny on hybrid transactions
such as M&A and licensing transactions, options toacquire companies or technology, development
arrangements and product divestitures. She advises
clients on transitional service, manufacturing andsupply, distribution, promotion, development, andclinical trial agreements and other operational
agreements throughout a product life cycle that often
accompany transactions.

Phone+44 20 7296 5124

Fax+44 20 7296 2001

Emailpenny.powell@hoganlovells.com

Languages
EnglishFrenchPractices
Commercial
Complex Contracting
Digital Assets and Blockchain
Joint Ventures
Mergers and Acquisitions
Corporate Governance and PublicCompany Representation
Strategic Operations, Agreements
and Regulation

Industries

Focusing on the life sciences, technology andautomotive industry sectors gives Penny an in-depth
understanding of relevant regulation as well as thepractical steps needed to implement it, which can be
critical to securing the optimal structural pathway for atransaction.

Automotive and MobilityConsumer
Life Sciences and Health Care
Technology and Telecoms

Representative experience

Areas of focus

Advising Novartis on the separation of their
Manufacturing and Supply arrangements as aconsequence of the spin off of Alcon and its listing on
SIX Swiss Exchange and New York Stock Exchange.

Technology Contracts
Agency and Distribution
IT Outsourcing
Logistics
Manufacturing
Outsourcing
Procurement
Disclosure and Reporting
Obligations
Fashion and Luxury Brands
Pharmaceuticals and Biotechnology
Licensing and Commercial
Transactions

Advising Alvotech on its exclusive strategic partnershipwith Teva re five biosimilar product candidates and on
manufacturing/licensing arrangements in the MENA
region/EU.
Advising Daimler AG on their investments in theMercedes AMG Petronas F1 Team and previously
advising on the Daimler investment in the McLaren
Team and Daimler's exit from that arrangement.
Advising Novartis on its pioneering collaboration with
Exactmer, CPI, and AstraZeneca to develop an
innovative/scalable manufacturing process foroligonucleotides.
Advising Sandoz AG on an exclusive development andlicensing agreement for innovative COPD inhalation
devices.

Education and admissions

Advising Shire PLC in relation to the acquisition of
Shire's oncology business by Servier.

LL.B.

Advising Sandoz AG on a global collaboration with
Biocon Biologics Limited, to develop, manufacture andcommercialize multiple biosimilars in immunology andoncology.
Advising a global technology company on its joint
venture with a global pharma company to enable theresearch, development and commercialisation ofbioelectronic medicines.
Advising Novartis on the addition of the fully humanmonoclonal antibody Ofatumumab to its MS portfolio,

Education

Accolades‘Penny Powell is brilliant, one of thebest life science and commercial
contracts lawyers I have comeacross. Her ability to get to theessence of any situation or
negotiation is unparalleled. Brilliantthrough its $1bn acquisition of the rights to the samefrom GSK.
Advising Novartis on the purchase of GSK’s cancer
division and the establishment of the transitional
support arrangements for the Parties' joint consumer
health joint venture.

Awards and rankings
Next Generation Partner – Life Sciences andHealthcare, Legal 500 UK, 2024
Next Generation Partner – Commercial Contracts,
Legal 500 UK, 2024

Latest thinking and events
Hogan Lovells Events
Tokyo: Life Sciences and Health Care Horizons
2024
Press releases
Hogan Lovells advises Recordati on the acquisitionof Enjaymo® for a consideration of US$825
million plus additional commercial milestone
payments of up to US$250 millionNews
UK passes Automated Vehicles Act 2024
Hogan Lovells Events
Fireside chats with Hogan Lovells during JPM 2024
Hogan Lovells Events
J.P. Morgan Healthcare Conference
NewsJPM2024: Manufacturing outlook fortransformative technologies

negotiator, and she often knows
better than the client what they
actually need.’

Legal 500 UK, 2024